SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is currently trending as investors monitor ivonescimab's potential to disrupt the oncology market, with heavy focus on its head-to-head performance against Keytruda. The community is actively debating the company's future ahead of upcoming clinical data, balancing optimism about its transformative pipeline against concerns regarding competition and clinical trial timelines.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is trending as investors react to a failed acquisition attempt by Merck, which reportedly pulled out of talks due to valuation disagreements, while the community continues to closely track upcoming Phase 3 clinical data for its leading oncology candidate, daraxonrasib.

This has been pretty requested, so here's a short explainer of what $Staccana is:  @STACCoverflow has cooked up a Solana fork using some tech that was created, but never utilized since Solana cannot rollback or change inherent promises the chain makes. Here are the promises that Staccana chain makes:  a. Token transfers are encrypted by default b. Launches use frequent-batch auctions (MEV is not possible on this chain)  I've been coordinating with Stacc to help create a flywheel for this meme coin and the native ssSOL token. If you want early access to the chain, best rewards, and to become a part of this ecosystem you want to be invested in $Staccana.  Said flywheel is being cooked by Stacc as we speak, and the plan is to release Staccana main net on May 16th. I will be contributing the locked 4.6% supply to LPs for the flywheel.  Creator fees will be used to bootstrap the network, incentivize early users, and to add to the Stacanna treasury.  73edX6xoGY4v5y2hzuKdrUbJXLntqgmo74au1Ki1pump

Solana Fork Staccana

Staccana is generating buzz as investors track the project's upcoming mainnet launch and its focus on privacy-centric infrastructure for the Solana ecosystem. While some community members highlight the project's development and liquid staking potential as key drivers, others remain focused on recent large buy transactions and the anticipation of long-term utility.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos is trending as investors debate whether the token is at a critical floor or nearing further downside, with the community split between bearish "suckers" narrative and speculative interest in real-world asset tokenization. The conversation is dominated by intense skepticism regarding long-term growth and a high-stakes sentiment battle over whether the current price action signals a recovery or a continuation of a long-term downtrend.

Virgin Galactic Holdings, Inc. is an aerospace and space travel company, which engages in the provision of consumer space experience using reusable spaceflight systems. The firm is also involved in designing, developing, and manufacturing, ground and flight testing, spaceflight operation, and post-flight maintenance of spaceflight systems. The company was founded on May 5, 2017 and is headquartered in Tustin, CA.

Virgin Galactic Holdings Inc - Ordinary Shares - Class A

Virgin Galactic Holdings Inc

Virgin Galactic is experiencing significant retail-driven momentum as investors speculate on a short squeeze and draw parallels to the upcoming SpaceX IPO, leading to intense debate over the company's long-term business viability. The community remains deeply divided between those betting on an explosive run based on technical setups and others warning of a potential pump-and-dump scenario.

SAP SE engages in the provision of enterprise application software and software-related services. It operates through the following segments: Applications, Technology, and Support; Qualtrics; and Services. The Applications, Technology, and Services segment includes sale of software licenses, support offerings, and cloud subscriptions. The Qualtrics segment sells experience management cloud solutions. The Services segment offers professional services, premium support services, implementation services for software products, and education services on the use of products. The company was founded by Hasso Plattner, Klaus Tschira, Claus Wellenreuther, Dietmar Hopp, and Hans-Werner Hector on April 1, 1972 and is headquartered in Walldorf, Germany.

Sap SE - ADR

SAP AG

SAP is currently trending due to active community debate surrounding the long-term software profit landscape, where investors are weighing its ERP dominance and steady cloud compounding against emerging competitors. While some community members highlight its institutional positioning and recent AI integration efforts, others are debating whether its valuation and cloud growth trajectories justify its market position relative to more aggressive AI-focused rivals.

Stellar is an open-source, decentralized network co-founded in 2014 by Jed McCaleb and Joyce Kim to facilitate the fast and low-cost transfer of value across different currencies and assets globally. Managed by the non-profit Stellar Development Foundation, the project serves as a global infrastructure that connects banks, payment systems, and individuals to expand financial access to underserved populations. Its main value proposition lies in providing a bridge between traditional money and digital networks through the use of Anchors, which are trusted entities that hold deposits and issue credits on the ledger.  The network operates using the Stellar Consensus Protocol and a Federated Byzantine Agreement, where nodes choose trusted sets of other nodes to agree on the state of the ledger. This system ensures high throughput and fast finality, where transactions are considered permanent and irreversible within seconds. Key features include a built-in distributed exchange for trading assets without intermediaries and the Soroban platform for developing smart contracts. Users can also utilize the network for tokenizing real-world assets or accessing decentralized finance services like peer-to-peer lending.  Stellar's native token, XLM, is essential for maintaining network integrity by acting as an intermediary to find efficient exchange paths and preventing spam through small transaction fees and minimum account balance requirements. Unlike many other digital assets, the network has no inflation because the community voted to disable the automatic creation of new tokens. While the project received early funding from the payments company Stripe, it is now sustained by a global community of validators and developers rather than traditional venture capital.

Stellar Lumens

Stellar Lumens is trending due to a significant institutional partnership with the Depository Trust and Clearing Corporation, which plans to integrate tokenized assets onto the Stellar network. Investors are actively discussing the potential for massive long-term network adoption, comparing the project's utility to traditional finance, and debating whether current price action signals a breakout or a temporary pump.

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

Hyperliquid Strategies Inc. (PURR) is trending as traders speculate on a potential short squeeze, driven by significant institutional accumulation and its role as a proxy for the rapidly expanding Hyperliquid perpetual futures exchange. The community is actively discussing the stock's massive daily volume and the broader integration of tokenized assets into the U.S. financial system, fueling expectations of a long-term structural rally.

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.

Immunome Inc

Immunome is trending following the successful Phase 3 RINGSIDE trial results for Varegacestat, which showed significant improvements in progression-free survival for desmoid tumor patients. The stock is seeing heavy community discussion around its potential for a buyout, strong insider conviction through recent CEO purchases, and excitement over its high-intensity pipeline of oncology assets.

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Miami, FL.

Pulse Biosciences Inc

Pulse Biosciences is trending due to heightened investor interest surrounding a rights offering and significant insider accumulation from leadership, signaling confidence in its novel nanosecond pulsed field ablation technology. Community discussion is heavily focused on the company's long-term commercial potential in the cardiac and soft tissue markets, with many participants actively monitoring the stock for a short squeeze setup.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


go88vipro2024

GO88